Tag: cguard embolic prevention system

January 24, 2019

InspireMD Announces Presentation of Interim Data from Investigator-Initiated Study

InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of...
January 23, 2019

InspireMD Announces Two Successful Live Clinical Case Transmissions Featuring CGuard EPS

InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of...
January 14, 2019

InspireMD Announces the Distribution of CGuard Embolic Prevention System in South Africa

InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of...
November 29, 2018

InspireMD’s CGuard Product Receives Approvals in Australia

Australia's regulatory agency has granted approval for the device, which prevents stroke caused by the treatment of carotid artery disease.
November 28, 2018

InspireMD Announces Regulatory and Reimbursement Approval of CGuard Embolic Prevention System in Australia

InspireMD (NYSE American:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment...
September 17, 2018

InspireMD Announces Issuance of Two New U.S. Patents Covering Proprietary MicroNet Stent Jacket and Related Drug Eluting Technology

InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of...